RHOT1 and Parkinson disease: Particularly in the context of PD, PD-associated mutations in Parkin were shown to disrupt the ubiquitination of Miro1 for proteasomal degradation in patient-derived fibroblasts, leading to the inhibition of Miro1 turnover and the subsequent failure of mitochondrial arrest for mitophagy (Figure 1B) (7).